Antibiotics and Innovation


Antibiotics save untold numbers of human lives every day. Modern medicine depends on their ability to treat infections such as pneumonia and tuberculosis. Yet drug-resistant bacteria are spreading in the nation’s communities and too often antibiotics are taken for granted. The U.S. Centers for Disease Control and Prevention estimates that tens of thousands of Americans die each year from infections, and many of those deaths are associated with bacteria that are resistant to treatment by one or more of these drugs. In the past few years, so-called “superbugs” have emerged that cause an even greater public health concern.

The Pew Charitable Trusts’ antibiotics and innovation project develops and supports policies that will spur innovation of new antibiotics to fight infections today and to ensure a healthy nation in the future.

Project Team

Elizabeth Jungman, director, Drug Safety and Innovation

Allan Coukell, senior director, Drugs and Medical Devices

Media Contact

Linda Paris

Officer, Communications